Ajanta Pharma Ltd Company Profile
✉ Email this page to a colleague
What is the competitive landscape for AJANTA PHARMA LTD, and what generic and branded alternatives to AJANTA PHARMA LTD drugs are available?
AJANTA PHARMA LTD has sixty-four approved drugs.
There are three tentative approvals on AJANTA PHARMA LTD drugs.
Summary for Ajanta Pharma Ltd
US Patents: | 0 |
Tradenames: | 54 |
Ingredients: | 53 |
NDAs: | 64 |
Drug Master File Entries: | 2 |
Drugs and US Patents for Ajanta Pharma Ltd
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ajanta Pharma Ltd | TOFACITINIB CITRATE | tofacitinib citrate | TABLET;ORAL | 212943-001 | Jun 1, 2021 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Ajanta Pharma Ltd | OMEPRAZOLE AND SODIUM BICARBONATE | omeprazole; sodium bicarbonate | CAPSULE;ORAL | 204228-001 | Jul 15, 2016 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Ajanta Pharma Ltd | SILODOSIN | silodosin | CAPSULE;ORAL | 211060-002 | Dec 3, 2018 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Ajanta Pharma Ltd | OSELTAMIVIR PHOSPHATE | oseltamivir phosphate | FOR SUSPENSION;ORAL | 212784-001 | May 27, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.